On April 30, 2026, a significant number of insiders at Heartflow, Inc. (HTFL) divested their holdings, with a total of approximately $286.04 million in shares being sold. The transactions involved multiple entities, including Capital Life Sciences Fund Iii, L.P., Capital Life Sciences Investors, Llc, Fund Iii Investments Gp, Llc, and Capital Life Sciences Iii General Partner, Llc.
These sales occurred across several tranches at varying price points, with individual sales ranging from $7.75 million to $26.04 million. The largest single transaction saw Capital Life Sciences Fund Iii, L.P., Capital Life Sciences Investors, Llc, Fund Iii Investments Gp, Llc, Capital Life Sciences Iii General Partner, Llc, and Fund Iii Investments, Lp each sell 892,533 shares at $29.18 per share.
While insider sales can be motivated by various factors such as portfolio diversification or tax planning, a coordinated divestment by multiple insiders may attract investor attention.